ZYNERBA PHARMACEUTICALS INC

NASDAQ

ZYNE

Zynerba Pharmaceuticals has been surging since it got added to the Russell 2000 and 3000 indices. It is in an upward channel, just broke trendline resistance, and looks strong on the indicators, including high buying volume. It will meet short-term resistance around 16.47. Look for a break above that level on volume.

Double bottom in an uptrend: - The double bottom looks like the letter "W". The twice-touched low is considered a support level. - The advance of the first bottom should be a drop of 10% to 20%, then the second bottom should form within 3% to 4% of the previous low, and volume on the ensuing advance should increase. - The double bottom pattern always follows a...

IF this impulse has more legs, looking at the golden box for a reaction. if we miss or blast trough, recount and reconsider what this is, this is 1 of many possibilities

to the channel bottom which is where my buy zone lies.

Just as planed . Looks like next week we Might get the "randevo" with the 50 DMA

A biotech company related to the cannabis sector focused on the development of synthetic cannabinoid treatments for transdermal (through the skin) delivery. Looking forward 4 the next flirt with the 50 DMA to start my long accumulation (if and when)

I’m not entirely happy with this play, but based on the volume and other factors on the chart, I’m going to go with it. The good: price is bouncing off the top of the cloud and is above the conversion line. The not-so-good: it pegged the conversion line, but didn’t close over it. So the conversion line may pose some resistance. Entry will be just above Friday’s...

Zyne had favorable news pushing the stock price higher from the pullback in May 2019. finance.yahoo.com Limit Order @ 13 Target @ 16 Stop Loss @ 11

Although $ZYNE is developing some bull strength, it is still in a large bear trend or trading range. The bulls reversed the market up on the monthly chart from a large high 2, and will probably get some form of a second leg up. However since the IPO this market has been sideways to down, decreasing the likelihood of a strong bull trend developing. The bulls...

The first bounce from the daily 50EMA was nice, do we get a second one?

Closed strong above the resistance line today. Bullish divergence in the RSI. MACD about to cross bullish on the 4-hour. I'll be watching for heavy volume and continuation. S and P may have to consolidate first...

Another winner!

And a swing back up from $8, where we have support

Or maybe it needs to go down to Fib 50. Or even lower at 61.8 to test the lower channel.

Zynerba crashed into resistance at at $16.50 on May 17th 2019, and went into correction territory. The engulfing candlestick today May 29th, 2019 is a very bullish sign ZYNE could go up to at least the $16.50 line. Technicals are not great, however I expect them to start confirming the bullish trend soon. Recommended trade: Long: $13.15 (20SMA) Sell-target:...

ZYNE correction is not over yet.

I got in at $3.66. Been in and out, trying to sell the rallies and buy the dip. It has been an interesting ride with some extreme gains. Needless to say that my position is bullish. So... what's next? My play with ZYNE is aimed at the CBD legislation that is expected at around October this year. ZYNE has many good patents, ready to market, and once CBD as an...

ZYNE is in the process of ABC correction as projected in the chart